Skip to content
TrialMatch
Sign up
Recruiting

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE

Create a profile to match View the full record on ClinicalTrials.gov

About this study

This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.

Condition
Prostate Cancer, Biochemical Relapse Fo Malignant Neoplasm of Prostate, Prostate Adenocarcinoma, Prostate Cancer Recurrent
Sponsor
Azienda Ospedaliero-Universitaria Careggi

Who can join

Age
18 years and older
Sex
Male only
Healthy volunteers
Not accepted

Inclusion 6

  • Minimum age: 18 years
  • Eligible sex: Male
  • Study condition: Prostate Cancer, Biochemical Relapse Fo Malignant Neoplasm of Prostate, Prostate Adenocarcinoma, Prostate Cancer Recurrent
  • Signed informed consent
  • Age \>18
  • Patient suitable for 68Ga-PSMA PET/CT re-staging according to clinical practice (Previous radical prostatectomy with histological result of Prostate adenocarcinoma +/- postoperative prostate bed radiotherapy (adjuvant or salvage setting), with a biochemical relapse defined as a PSA \> 0.2 and \<1

Exclusion 2

  • ADT administration within 6 months from study enrollment
  • Persistent elevation of PSA after RP measured within 16 weeks from surgery (\> 0.1 ng/ml)

Where

1 site, 1 recruiting

AOU Careggi Radiation Oncology Unit

Florence, Italy

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.